Sign In

Login

Password

Forgot Password ? Sign Up

تولواپتان فسفات (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "تولواپتان فسفات" in Persian language version.

refsWebsite
Global rank Persian rank
2doi.org
2nd place
2nd place
2nih.gov
4th place
5th place
2semanticscholar.org
11th place
52nd place

doi.org

  • Kinugawa K, Nakata E, Hirano T, Kim S (March 2022). "Tolerability of the Intravenously Administered Tolvaptan Prodrug, OPC-61815, in Patients With Congestive Heart Failure Who Have Difficulty With, or Are Incapable of, Oral Intake (TRITON-HF) - A Phase III, Multicenter, Open-Label Trial". Circulation Journal. doi:10.1253/circj.CJ-21-0926. PMID 35264514. S2CID 247362001.
  • Sato N, Uno S, Yamasaki Y, Hirano T, Kim S (March 2022). "Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of OPC-61815, a Prodrug of Tolvaptan for Intravenous Administration, in Patients With Congestive Heart Failure - A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Trial". Circulation Journal. 86 (4): 699–708. doi:10.1253/circj.CJ-21-0430. PMID 34511586. S2CID 237493273.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Kinugawa K, Nakata E, Hirano T, Kim S (March 2022). "Tolerability of the Intravenously Administered Tolvaptan Prodrug, OPC-61815, in Patients With Congestive Heart Failure Who Have Difficulty With, or Are Incapable of, Oral Intake (TRITON-HF) - A Phase III, Multicenter, Open-Label Trial". Circulation Journal. doi:10.1253/circj.CJ-21-0926. PMID 35264514. S2CID 247362001.
  • Sato N, Uno S, Yamasaki Y, Hirano T, Kim S (March 2022). "Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of OPC-61815, a Prodrug of Tolvaptan for Intravenous Administration, in Patients With Congestive Heart Failure - A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Trial". Circulation Journal. 86 (4): 699–708. doi:10.1253/circj.CJ-21-0430. PMID 34511586. S2CID 237493273.

semanticscholar.org

api.semanticscholar.org

  • Kinugawa K, Nakata E, Hirano T, Kim S (March 2022). "Tolerability of the Intravenously Administered Tolvaptan Prodrug, OPC-61815, in Patients With Congestive Heart Failure Who Have Difficulty With, or Are Incapable of, Oral Intake (TRITON-HF) - A Phase III, Multicenter, Open-Label Trial". Circulation Journal. doi:10.1253/circj.CJ-21-0926. PMID 35264514. S2CID 247362001.
  • Sato N, Uno S, Yamasaki Y, Hirano T, Kim S (March 2022). "Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of OPC-61815, a Prodrug of Tolvaptan for Intravenous Administration, in Patients With Congestive Heart Failure - A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Trial". Circulation Journal. 86 (4): 699–708. doi:10.1253/circj.CJ-21-0430. PMID 34511586. S2CID 237493273.